Infections with spore-forming bacteria in persons who inject drugs, 2000-2009

Emerging Infectious Diseases

Volumn 19, Issue 1, 2013, Pages 29-34

  Palmateer, Norah E ^a   Hope, Vivian D ^b,c   Roy, Kirsty ^a   Marongiu, Andrea ^b   White, Joanne M ^b   Grant, Kathie A ^b   Ramsay, Colin N ^a   Goldberg, David J ^a   Ncube, Fortune ^b  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BACTERIAL SPORE; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI; DRUG DEPENDENCE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK FACTOR;

ADULT; ANTHRAX; BACILLUS ANTHRACIS; BOTULISM; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM TETANI; DISEASE OUTBREAKS; DRUG CONTAMINATION; ENGLAND; FEMALE; HEROIN; HUMANS; INCIDENCE; MALE; SCOTLAND; SPORES, BACTERIAL; SUBSTANCE ABUSE, INTRAVENOUS; TETANUS;

EID: 84871632534     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1901.120044     Document Type: Article

References (37)

1. Brett MM, Hood J, Brazier JS, Duerden BI, Hahne SJ. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiol Infect. 2005;133:575-82. http:// dx.doi.org/10.1017/S0950268805003845
2. McLauchlin J, Mithani V, Bolton FJ, Nichols GL, Beilis MA, Syed Q, et al. An investigation into the microflora of heroin. J Med Microbiol. 2002;51:1001-8.
3. Sapira JD. The narcotic addict as a medical patient. Am J Med. 1968;45:555-88. http://dx.doi.org/10.1016/0002-9343(68)90172-1
4. Siegel H, Helpem M, Ehrenreich T. The diagnosis of death from intravenous narcotism. With emphasis on the pathologic aspects. J Forensic Sci. 1966;11:1-16.
5. Werner SB, Passaro D, McGee J, Schechter R, Vugia DJ. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin Infect Dis. 2000;31:1018-24. http://dx.doi. org/10.1086/318134
6. Hope VD, Palmateer N, Wiessing L, Marongiu A, White J, Ncube F, et al. A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation. Am J Public Health. 2012;102:122-5. http://dx.doi.org/10.2105/ AJPH.2011.300314
7. McGuigan CC, Penrice GM, Gruer L, Ahmed S, Goldberg D, Black M, et al. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. J Med Microbiol. 2002;51:971-7.
8. Health Protection Agency. Tetanus: information for health professionals. 2007 [cited 2012 Aug 15], http://www.hpa.org.uk/ webe IlI'Awebl ile HPAwcb C 1194947374762
9. Health Protection Agency. Wound botulism cases associated with injecting drug use. 2011 [cited 2012 Aug 15], http://www.hpa.org. uk/Topics/InfectiousDiseases/InfectionsAZ/Botulism/Generallnfor-mation/botu020WoundbotulismcasesassociatedwithIDU/
10. Taylor A, Hutchinson S, Lingappa J, Wadd S, Ahmed S, Gruer L, et al. Severe illness and death among injecting drug users in Scotland: a case-control study. Epidemiol Infect. 2005;133:193-204. http:// dx.doi.org/10.1017/S0950268804003504
11. Ramsay CN, Stirling A, Smith J, Hawkins G, Brooks T, Hood J, et al. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveill. 2010;15:19465.
12. National Anthrax Outbreak Control Team. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. Glasgow (UK): Health Protection Scotland, December 2011 [cited 2011 Dec 29], http://www.documents.hps.scot.nhs.uk/giz/anthrax-outbreak/anthrax-outbreak-report-2011-12.pdf
13. Hay G, Gannon M, MacDougall J, Millar T, Eastwood C, McKeganey N. Local and national estimates of the prevalence of opiate use and/or crack cocaine use. In: Singleton N, Murray R, Tinsley L, editors. Measuring different aspects of problem drug use: methodological developments. 2nd ed. London: Home Office; 2006. p. 3-40.
14. Hay G, Gannon M, Casey J, McKeganey N. Estimating the national and local prevalence of problem drug misuse in Scotland: executive report. Glasgow (UK): University of Glasgow; 2009 Aug [cited 2011 Dec 15], http://www.drugmisuse.isdscotland.org/publications/ local/Prevalence_2009.pdf
15. Hope VD, Judd A, Hickman M, Sutton A, Stimson GV, Parry JV, et al. HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years. AIDS. 2005;19:1207-14. http://dx.doi.org/10.1097/01. aids.0000176222.71355.al
16. University of the West of Scotland, Health Protection Scotland, West of Scotland Specialist Virology Centre. The Needle Exchange Surveillance Inititative (NESI): prevalence of HCV and injecting risk behaviours among injecting drug users attending needle exchanges in Scotland, 2008/2009. Paisley (UK): University of the West of Scotland; 2010 Apr [cited 2011 Dec 15], http://www.hepcscotland. co.uk/media/50084/nesi-report-08-09.pdf
17. United Nations Office on Drugs and Crime. World drug report 2009. Vienna: The Office; 2009.
18. Serious Organised Crime Agency. The United Kingdom threat assessment of organised crime 2009-2010. 2010 [cited 2011 Dec 15], http://www.soca.gov.uk/about-soca/library?start=l0
19. Ringertz SH, Hoiby EA, Jensenius M, Maehlen J, Caugant DA, Myklebust A, et al. Injectional anthrax in a heroin skin-popper. Lancet. 2000;356:1574-5. http://dx.doi.org/10.1016/S0140-6736(00)03133-0
20. Caugrant DA, Fossum K, Hoel T, Hoiby EA, Iversen BG, Jensenius M, et al. Systemic anthrax in an injecting drug user: Oslo, Norway, April 2000. Euro Surveill. 2000;4:1605.
21. Cole C, Jones L, McVeigh J, Kicman A, Syed Q, Beilis M. Adulterants in illicit drugs: a review of empirical evidence. Drug Test Anal. 2011;3:89-96. http://dx.doi.org/10.1002/dta.220
22. Horowitz BZ, Swensen E, Marquardt K. Wound botulism associated with black tar heroin. JAMA. 1998;280:1479-80. http://dx.doi. org/10.1001 /jama.280.17.1479
23. Nicolaier A. On infectious tetanus [in German], Dtsch Med Wochenschr. 1884;10:842-4. http://dx.doi.org/10.1055/s-0028-1143432
24. Peek SF, Semrad SD, Perkins GA. Clostridial myonecrosis in horses (37 cases 1985-2000). Equine Vet J. 2003;35:86-92. http://dx.doi. org/10.2746/042516403775467513
25. Hahné SJ, White JM, Crowcroft NS, Brett MM, George RC, Beeching NJ, et al. Tetanus in injecting drug users, United Kingdom. Emerg Infect Dis. 2006;12:709-10. http://dx.doi.org/10.3201/ eidl204.050599
26. Akbulut D, Dennis J, Gent M, Grant KA, Hope V, Ohai C, et al. Wound botulism in injectors of drugs: upsurge in cases in England during 2004. Euro Surveill. 2005;10:172-4.
27. Hankins C, Palmer D, Singh R. Unintended subcutaneous and intramuscular injection by drug users. CMAJ. 2000;163:1425-6.
28. Graham CA, McNaughton GW, Crawford R. 'Popping': a cause of soft tissue sepsis in chronic drug abusers. Eur J Emerg Med. 1999;6:259-61. http://dx.doi.org/10.1097/00063110-199909000-GO016
29. Dwyer R, Topp L, Maher L, Power R, Hellard M, Walsh N, et al. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug Alcohol Depend. 2009;100:9-16. http://dx.doi.Org/10.1016/j. drugalcdep.2008.08.016
30. Hope VD, Marongiu A, Parry JV, Ncube F. The extent of injection site infection in injecting drug users: findings from a national surveillance study. Epidemiol Infect. 2010;138:1510-8. http:// dx.doi.org/10.1017/S0950268810000324
31. English L. Treatment and care for older drug users. In: Eaton D, Davies G, English L, Lodwick A, Beilis M, McVeigh J, editors. National report to the EMCDDA by the Reitox National Focal Point United Kingdom: new developments. London: UK Focal Point; 2009. p. 203-23.
32. Health Protection Agency. Anthrax: information on 2010 outbreak. 2011 [cited 2011 Dec 15], http://www.hpa.org.uk/web/ HPAweb&Page&HPAwebAutoListName/Page/l 265637163487
33. Baymiller S. Botulism in critical care: a case study in wound botulism. Am J Crit Care. 2001; 10:172-80.
34. Wenham T, Cohen A. Botulism. Continuing Education in Anaesthesia. Critical Care & Pain. 2008;8:21-5.
35. Cook TM, Protheroe RT, Handel JM. Tetanus: a review of the literature. Br J Anaesth. 2001;87:477-87. http://dx.doi.org/10.1093/ bja/87.3.477
36. Rushdy AA, White JM, Ramsay ME, Crowcroft NS. Tetanus in England and Wales, 1984-2000. Epidemiol Infect. 2003;130:71-7. http://dx.doi.org/10.1017/S0950268802007884
37. Hickman M, Higgins V, Hope V, Beilis M, Tilling K, Walker A, et al. Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators. J Epidemiol Community Health. 2004;58:766-71. http://dx.doi. org/10.1136/jech.2003.015164